4.7 Article

Magnetisation transfer ratio combined with magnetic resonance neurography is feasible in the proximal lumbar plexus using healthy volunteers at 3T

Journal

SCIENTIFIC REPORTS
Volume 10, Issue 1, Pages -

Publisher

NATURE RESEARCH
DOI: 10.1038/s41598-020-71570-1

Keywords

-

Funding

  1. UK Multiple Sclerosis Society
  2. National Institute for Health Research University College London Hospitals Biomedical Research Centre

Ask authors/readers for more resources

Magnetic resonance neurography (MRN) has been used extensively to study pathological conditions affecting the peripheral nervous system (PNS). However, tissue damage is assessed qualitatively with little information regarding the underlying pathophysiological processes involved. Magnetisation transfer ratio (MTR) is a quantitative magnetic resonance imaging method which is sensitive to tissue macromolecular content and may therefore have an important role in the study of pathologies affecting the PNS. This study explored the feasibility of obtaining reliable MTR measurements in the proximal lumbar plexus of healthy volunteers using MRN to identify and segment each lumbar segment (L2-L5) and regions (preganglionic, ganglionic and postganglionic). Reproducibility of the MTR measurements and of the segmentation method were assessed from repeated measurements (scan-rescan), and from the reanalysis of images (intra- and inter-rater assessment), by calculating the coefficient of variation (COV). In all segments combined (L2-L5), mean (+/- SD) MTR was 30.5 (+/- 2.4). Scan-rescan, intra- and inter-rater COV values were 3.2%, 4.4% and 5.3%, respectively. One-way analysis of variance revealed a statistically significant difference in MTR between the preganglionic and postganglionic regions in all lumbar segments. This pilot study in healthy volunteers demonstrates the feasibility of obtaining reliable MTR measurements in the proximal lumbar plexus, opening up the possibility of studying a broad spectrum of neurological conditions in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Clinical Neurology

New Evidence for Epstein-Barr Virus Infection as a Cause of Multiple Sclerosis

Yael Hacohen, Olga Ciccarelli

NEUROLOGY (2022)

Article Clinical Neurology

B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple Sclerosis

Marcello Moccia, Lukas Haider, Arman Eshaghi, Steven Harry Pieter van de Pavert, Vincenzo Brescia Morra, Amy Patel, Claudia Angela Michela Wheeler-Kingshott, Frederik Barkhof, Olga Ciccarelli

Summary: Perivascular B cells in progressive multiple sclerosis are associated with worse clinical outcomes and CNS inflammation.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Article Clinical Neurology

Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis

Vivien Li, Baptiste Leurent, Frederik Barkhof, Marie Braisher, Fay Cafferty, Olga Ciccarelli, Arman Eshaghi, Emma Gray, Jennifer M. Nicholas, Mahesh Parmar, Guy Peryer, Jenny Robertson, Nigel Stallard, James Wason, Jeremy Chataway

Summary: This article introduces how to accelerate the evaluation of new therapies for progressive multiple sclerosis (PMS) using the multi-arm multistage (MAMS) platform trial. Through the review of past PMS trials and simulation trials, the selection and design measures for interim and final outcomes are determined. To reduce the duration and sample size, the proposed MAMS trial design is recommended to replace traditional clinical trials.

NEUROLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Multi-echo quantitative susceptibility mapping: how to combine echoes for accuracy and precision at 3 Tesla

Emma Biondetti, Anita Karsa, Francesco Grussu, Marco Battiston, Marios C. Yiannakas, David L. Thomas, Karin Shmueli

Summary: This study compared different multi-echo combination methods for MRI QSM and recommended combining the signal phase by nonlinear fitting before applying LBMs to improve regional accuracy and reduce phase noise.

MAGNETIC RESONANCE IN MEDICINE (2022)

Review Neurosciences

Italian, European, and international neuroinformatics efforts: An overview

Alberto Redolfi, Damiano Archetti, Silvia De Francesco, Claudio Crema, Fabrizio Tagliavini, Raffaele Lodi, Roberta Ghidoni, Claudia A. M. Gandini Wheeler-Kingshott, Daniel C. Alexander, Egidio D'Angelo

Summary: Neuroinformatics is a research field that focuses on software tools for identifying, analyzing, modeling, organizing, and sharing neuroscience data. With the emergence of big data, neuroinformatics has experienced rapid growth in the past two decades, enabling neuroscientists to acquire and process data faster and more cost-effectively. To address this, neuroimaging-focused neuroinformatics platforms have been developed, aiming to archive and organize data, develop data-driven models, and provide computational and storage resources.

EUROPEAN JOURNAL OF NEUROSCIENCE (2023)

Article Clinical Neurology

Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study

Maria A. Rocca, Paola Valsasina, Alessandro Meani, Claudio Gobbi, Chiara Zecca, Frederik Barkhof, Menno M. Schoonheim, Eva M. Strijbis, Hugo Vrenken, Antonio Gallo, Alvino Bisecco, Olga Ciccarelli, Marios Yiannakas, Alex Rovira, Jaume Sastre-Garriga, Jacqueline Palace, Lucy Matthews, Achim Gass, Philipp Eisele, Carsten Lukas, Barbara Bellenberg, Monica Margoni, Paolo Preziosa, Massimo Filippi

Summary: Spinal cord damage and, to a lesser extent, cortical volume loss are associated with worse 5-year clinical outcomes in multiple sclerosis patients.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel Biomarkers

Gilbert Thomas-Black, Daniel R. Altmann, Harry Crook, Nita Solanky, Ferran Prados Carrasco, Marco Battiston, Francesco Grussu, Marios C. Yiannakas, Baris Kanber, Jasleen K. Jolly, Jon Brett, Susan M. Downes, Marni Moran, Ping K. Chan, Emmanuel Adewunmi, Claudia A. M. Gandini Wheeler-Kingshott, Andrea H. Nemeth, Richard Festenstein, Fion Bremner, Paola Giunti

Summary: This study comprehensively evaluated the degeneration of the retina in FRDA patients and found heterogeneity in different retinal sectors. The thickness of the retinal nerve fiber layer was associated with frataxin levels. These findings have implications for future clinical trial design.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

HLA-DRB1*1501 influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosis

Wallace J. Brownlee, Carmen Tur, Andreea Manole, Arman Eshaghi, Ferran Prados, Katherine A. Miszkiel, Claudia A. M. Gandini Wheeler-Kingshott, Henry Houlden, Olga Ciccarelli

Summary: This study found that HLA-DRB1*1501 is associated with the severity of multiple sclerosis (MS), as indicated by long-term disability worsening and greater extent of inflammatory disease activity and tissue loss. HLA-DRB1*1501 may provide useful information for prognosis and treatment decisions in early relapse-onset MS.

MULTIPLE SCLEROSIS JOURNAL (2023)

Editorial Material Clinical Neurology

Message From the Editors to Our Reviewers

Jose G. R. Merino, Olga O. Ciccarelli, Bradford Worrall, Whitley W. Aamodt, Anthony Amato, Rebecca A. Burch, Peter C. Hedera, Linda M. Hershey, Barbara Jobst, Amy C. E. Kunchok, Andrea L. C. Schneider, Renee A. Shellhaas, Roy Strowd

NEUROLOGY (2023)

Editorial Material Clinical Neurology

Navigating Through the Recent Diagnostic Criteria for MOGAD Challenges and Practicalities

Olga Ciccarelli, Ahmed T. Toosy, Alan Thompson, Yael Hacohen

Summary: The Lancet Neurology((R)) published international criteria for the diagnosis of myelin oligodendrocyte glycoprotein-associated disease (MOGAD) on January 24, 2023. According to these criteria, patients with clinical events typically associated with MOG antibody (Ab) and clear positive serum MOG-Ab results can be diagnosed with MOGAD. Patients with low positive serum MOG-Ab titers can also be diagnosed if they possess supporting clinical or MRI features. Exclusion of alternative diagnoses, including multiple sclerosis (MS), is required.

NEUROLOGY (2023)

Editorial Material Clinical Neurology

Introducing a New Process for Methodologic and Statistical Review in Neurology

Jose G. Merino, Andrea L. C. Schneider, Olga Ciccarelli

Summary: Neurology aims to publish important research questions and use robust methods with transparent reporting. They rely on internal and external peer reviewers as well as methods experts to evaluate manuscripts. Drs. Kryscio, Leurgans, and Pankratz have been dedicated to evaluating these manuscripts for many years.

NEUROLOGY (2023)

Article Clinical Neurology

Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis

Alberto Calvi, Zoe Mendelsohn, Weaam Hamed, Declan Chard, Carmen Tur, Jon Stutters, David MacManus, Baris Kanber, Claudia A. M. Gandini Wheeler-Kingshott, Frederik Barkhof, Ferran Prados

Summary: This study retrospectively analyzed a fingolimod trial in patients with primary progressive MS (PPMS) and found that newly appearing lesions are common and can develop into chronic active lesions. Treatment can reduce the number of these lesions.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

2D sodium MRI of the human calf using half-sinc excitation pulses and compressed sensing

Rebecca R. Baker, Vivek Muthurangu, Marilena Rega, Javier Montalt-Tordera, Samuel Rot, Bhavana S. Solanky, Claudia A. M. Gandini Wheeler-Kingshott, Stephen B. Walsh, Jennifer A. Steeden

Summary: This study validated the use of 2D sodium MRI with half-sinc excitation and compressed sensing (CS) for quantifying tissue sodium concentration (TSC) with a resolution of 2.25 x 2.25 mm(2) and scan times of <= 5 mins.

MAGNETIC RESONANCE IN MEDICINE (2023)

Article Neuroimaging

MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies

Nicola De Stefano, Marco Battaglini, Deborah Pareto, Rosa Cortese, Jian Zhang, Niels Oesingmann, Ferran Prados, Maria A. Rocca, Paola Valsasina, Hugo Vrenken, Claudia A. M. Gandini Wheeler-Kingshott, Massimo Filippi, Frederik Barkhof, Alex Rovira

Summary: There is an increasing need to share harmonized data from large, cooperative studies for the development of new diagnostic and prognostic biomarkers. In the field of multiple sclerosis (MS), the harmonization of acquisition, analysis, and storage of large-scale multicentre MRI data is of paramount importance. Despite the advances made, further research and specialized resources are required to address the complexity of these tasks.

NEUROIMAGE-CLINICAL (2022)

No Data Available